Seelos Therapeutics Balance Sheet Health
Financial Health criteria checks 2/6
Seelos Therapeutics has a total shareholder equity of $-33.5M and total debt of $14.2M, which brings its debt-to-equity ratio to -42.4%. Its total assets and total liabilities are $5.4M and $38.9M respectively.
Key information
-42.4%
Debt to equity ratio
US$14.21m
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.00m |
| Equity | -US$33.51m |
| Total liabilities | US$38.93m |
| Total assets | US$5.42m |
Recent financial health updates
Recent updates
Seelos: Data This Year Is Critical
Oct 04Seelos wins Parkinson’s research grant for gene therapy program
Aug 24Seelos: FDA Action Makes It Highly Attractive
Dec 22Seelos Therapeutics: Shares Have Finally Found A Floor But Risk Remains
Oct 01We're Hopeful That Seelos Therapeutics (NASDAQ:SEEL) Will Use Its Cash Wisely
Aug 18
Seelos: Superior Data, But Early Stage
Jun 09Seelos announces issuance of a patent for trehalose (SLS-005) in Australia
Jan 29Seelos' expects to commence SLS-005 study in rare neurological disease in H1 2021, shares up 6%
Jan 06Seelos Therapeutics' trehalose nabs Israel patent
Dec 21Seelos Therapeutics (SEEL) files for $200M mixed shelf, shares down 8%
Dec 16Seelos nabs US Orphan Drug status for SLS-005 in amyotrophic lateral sclerosis
Nov 19Financial Position Analysis
Short Term Liabilities: SEEL has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: SEEL has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: SEEL has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: SEEL's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SEEL has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: SEEL is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.